Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma
NCT05328167Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Dec 2021
- Primary completion
- Jul 2025
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in intrahepatic cholangiocarcinoma (ICC), sponsored by Thomas Jefferson University. Started Dec 2021; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT05328167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05328167.